Speakers

More speakers are being announced each week through August and September.

Anthony L. Back, MD Anthony L. Back, MD Professor of Medicine University of Washington, Seattle
Ritu S. Baral Ritu S. Baral Managing Director & Sr. Biotechnology Analyst TD Cowen
Myriam Barthes Myriam Barthes CEO & Co-Founder Journey Clinical
Andrea Beckel-Mitchener, PhD Andrea Beckel-Mitchener, PhD Acting Director, National Institute of Mental Health National Institutes of Health
Daniel Bryant, MSEd, LPC, CCTP Daniel Bryant, MSEd, LPC, CCTP Clinical Director of Substance Use Disorder Services Community Health Center, Inc.
Al Bugazia, MD Al Bugazia, MD Deputy Director, Proactive Health ARPA-H
A.J. Cannon, MD A.J. Cannon, MD Medical Director, Neuroscience Clinical Development AbbVie
Joy Sun Cooper Joy Sun Cooper
Maj. Gen. Glenn H. Curtis (Ret.) Maj. Gen. Glenn H. Curtis (Ret.) Ambassador Americans for Ibogaine
Meghan DellaCrosse, PsyD Meghan DellaCrosse, PsyD Affiliate Scientist Johns Hopkins Center for Psychedelic and Consciousness Research
Caroline Dorsen, PhD, FNP-BC, FAAN Caroline Dorsen, PhD, FNP-BC, FAAN Senior Academic Advisor Psychedelic Education Partnership
Lori Englebert Lori Englebert Chief Commercial Officer Compass Pathways
Gisele Fernandes-Osterhold, LMFT Gisele Fernandes-Osterhold, LMFT Director of Psychedelic Facilitation, TrPR Program University of California San Francisco (UCSF)
Albert Garcia-Romeu, PhD Albert Garcia-Romeu, PhD Psychologist and Pharmacology Researcher Johns Hopkins Center for Psychedelic and Consciousness Research
Manesh Girn, PhD Manesh Girn, PhD Postdoctoral Neuroscientist University of California, San Francisco
Jazz Glastra Jazz Glastra Senior Director BrainFutures
Guy Goodwin, MD Guy Goodwin, MD Chief Medical Officer; Emeritus Professor, Oxford Compass Pathways
Andrew Gradison, JD Andrew Gradison, JD Senior Advisor, Veterans Health Administration U.S. Department of Veterans Affairs
Harry Grammer, PhD Harry Grammer, PhD Founder New Earth
Josh Hardman Josh Hardman Founder & Editor Psychedelic Alpha
Carole Ho, MD Carole Ho, MD Executive Vice President; President, Lilly Neuroscience Eli Lilly and Company
Julie Holland, MD Julie Holland, MD Psychiatrist Private practice, New York City
W. Bryan Hubbard, JD W. Bryan Hubbard, JD CEO Americans for Ibogaine
Edny Inui, PhD, MBA Edny Inui, PhD, MBA Partner Palo Santo
Daniel R. Karlin, MD, MA Daniel R. Karlin, MD, MA Chief Medical Officer Definium Therapeutics
Bia Labate, PhD Bia Labate, PhD Executive Director Chacruna Institute
Kyle LaHucik Kyle LaHucik Biotech Correspondent Endpoints News
Amy Lehrner, PhD Amy Lehrner, PhD Assistant Professor of Psychiatry Icahn School of Medicine at Mount Sinai
Alberto “Nachi” López Pérez Alberto “Nachi” López Pérez Board Member and Huachuma Conservation Center Director Colectivo Huachuma
Jason Luoma, PhD Jason Luoma, PhD Director of Research Portland Institute for Psychedelic Science
Valentina Mantua, MD, PhD Valentina Mantua, MD, PhD Associate Director for Regulatory Science U.S. Food and Drug Administration
Madison Muller Madison Muller Healthcare Reporter Bloomberg News
Austin R. Pick, MA Austin R. Pick, MA Program Director Psychedelic Education Partnership
Srinivas Rao, MD, PhD Srinivas Rao, MD, PhD Co-Founder and Chief Executive Officer, AtaiBeckley Eli Lilly and Company
Kate M. Reynolds, MPH Kate M. Reynolds, MPH Director of Research Rocky Mountain Poison & Drug Safety
Kimberly Roddy, MBA Kimberly Roddy, MBA Chief Operating Officer, Co-Founder Sunstone Therapies
Sandy Samberg, NP Sandy Samberg, NP Founder and Board Chair Psychedelic Education Partnership
Dalibor Sames, PhD Dalibor Sames, PhD Professor of Chemistry Columbia University
William M. Sauvé, MD William M. Sauvé, MD Chief Medical Officer Osmind
Erin Schumaker Erin Schumaker Deputy Health Care Editor Politico
Tanya Brara Shah Tanya Brara Shah Strategic Advisor Psychedelic Mental Health Access Alliance
Laurel Anne Sugden Laurel Anne Sugden Co-founder and Executive Director Colectivo Huachuma
Connor Williams Connor Williams Senior Research Analyst RTW Investments
Denali Wilson Denali Wilson New Mexico State Director of Strategic Support Healing Advocacy Fund
Rachel Yehuda, PhD Rachel Yehuda, PhD Chemers Neustein Family Professor of Trauma and Resilience Icahn School of Medicine at Mount Sinai
Jeffrey Zabinski, MD, MSW Jeffrey Zabinski, MD, MSW Director of Interventional Psychiatry Columbia University Irving Medical Center
Juliana Zambrano, MD, MPH Juliana Zambrano, MD, MPH Instructor of Psychiatry, Harvard Medical School Massachusetts General Hospital
Ariana Judith Zepeda, LCSW Ariana Judith Zepeda, LCSW Deputy Director New Earth
Matthew Zorn, JD Matthew Zorn, JD Deputy General Counsel U.S. Department of Health and Human Services
Kevin Balktick Kevin Balktick Founder + Director Horizons Media, Inc.